Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZyVersa Therapeutics, Inc.

0.2000
-0.1113-35.75%
Volume:1.29M
Turnover:252.49K
Market Cap:974.69K
PE:-0.02
High:0.2520
Open:0.1546
Low:0.1546
Close:0.3113
Loading ...

Company Profile

Company Name:
ZYVERSA THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
7
Office Location:
2200 N. Commerce Parkway,Suite 208,Weston,Florida,United States
Zip Code:
33326
Fax:
- -
Introduction:
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, IgA neuropathy, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. ZyVersa Therapeutics, Inc. was founded in 2014 and is headquartered in Weston, Florida.